Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,003 | 0,009 | 16:00 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08.05. | Wesana Health Holdings Inc: Wesana Health Holdings halted at the open | 1 | Stockwatch | ||
24.01. | Wesana Health Holdings Inc: Wesana Health appoints Monaghan, Purdy as directors | 1 | Stockwatch | ||
24.01. | Wesana Health Holdings Inc.: Wesana Health Announces Change to The Board of Directors | 762 | Newsfile | Chicago, Illinois and Toronto, Ontario--(Newsfile Corp. - January 24, 2025) - Wesana Health Holdings Inc. (CSE: WESA.X) (OTC Pink: WSNAF) (the "Company") is pleased to announce the appointment of Mark... ► Artikel lesen | |
WESANA HEALTH Aktie jetzt für 0€ handeln | |||||
17.10.24 | XFRA DDX: AUSSETZUNG/SUSPENSION | 279 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILWESANA HEALTH HOLD.... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS MEDICAL CARE | 48,300 | +0,52 % | ANALYSE-FLASH: Berenberg hebt Ziel für FMC auf 60 Euro - 'Buy' | HAMBURG (dpa-AFX Broker) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen | |
ESSILORLUXOTTICA | 233,70 | -0,38 % | BERNSTEIN RESEARCH stuft EssilorLuxottica auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für EssilorLuxottica auf "Market-Perform" mit einem Kursziel von 245 Euro belassen. Luca Solca befasste sich in... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,109 | +3,81 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
ALIGN TECHNOLOGY | 159,75 | -0,81 % | Reasons to Add Align Technology Stock to Your Portfolio Now | ||
NUGEN MEDICAL DEVICES | 0,033 | -5,75 % | NuGen Medical Devices - Lillys Geschichte: Ein Teenager aus Nordkanada… | ||
HEALWELL AI | 0,850 | -0,53 % | HEALWELL AI nutzt Orion Health für den Eintritt in den US-Markt | - HEALWELL führt eine Reihe von KI-gestützten Tools auf dem US-Markt ein, die das bestehende Softwareangebot von Orion Health in den USA ergänzen.
- Dadurch
werden die... ► Artikel lesen | |
INMODE | 12,345 | +1,73 % | InMode Ltd.: InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025 | YOKNEAM, Israel, May 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,745 | -2,49 % | Atossa Genetics Year-end 2024 slides: (Z)-endoxifen shows promise, expenses decline | ||
SPINEWAY | 0,118 | -1,67 % | Spineway: Minutes of the General Meeting of June 4, 2025 | Press release Ecully, June 6, 2025 - 6.00 p.m. SPINEWAY Minutes of the General Meeting of June 4, 2025 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders... ► Artikel lesen | |
ELEVANCE HEALTH | 319,70 | -1,90 % | Dividendenbekanntmachungen (25.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ASYMCHEM LABORATORIES TIANJIN CO LTD CNE100004Z06 1,2021 HKD 0,1319 EUR BANK FIRST CORPORATION US06211J1007 0,45 USD 0,3875 EUR BENETEAU... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,014 | -5,41 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
VERU | 0,565 | +9,51 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
ONTRAK | 0,532 | -45,31 % | Ontrak Prices $4 Mln Public Offering Of Shares And Warrants At $0.60 Each Share | ||
TENET | 146,00 | -1,35 % | Tenet Healthcare upgraded to BB- by S&P on improved performance |